20 min listen
Iron-restricted Erythropoiesis in Sickle Cell Disease, With Drs. David Rees, Naja Nyffenegger, & Vania Manolova
FromThe Hematologist
Iron-restricted Erythropoiesis in Sickle Cell Disease, With Drs. David Rees, Naja Nyffenegger, & Vania Manolova
FromThe Hematologist
ratings:
Length:
13 minutes
Released:
Sep 21, 2022
Format:
Podcast episode
Description
In this installment, Contributing Editor Dr. David Rees has a conversation with Drs. Naja Nyffenegger and Vania Manolova. They discuss the Blood article covered by Dr. Rees in his most recent Diffusion article titled, “Iron-restricted Erythropoiesis in Sickle Cell Disease.” In the article, Dr. Rees explored the study by Dr. Nyffenegger and colleagues, which hypothesized that iron restriction via blocking ferroportin might reduce sickle hemoglobin concentration in red blood cells, thereby decreasing hemolysis, improving blood flow, and preventing vaso-occlusive events. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.5.202256/486443/Iron-restricted-Erythropoiesis-in-Sickle-Cell.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Sep 21, 2022
Format:
Podcast episode
Titles in the series (100)
The Unfiltered Truth: Anticoagulation Alone is Highly Effective, even in Patients with High-risk PE: In his recent Diffusion article from the July/August issue of The Hematologist, Dr. David Garcia (University of Washington School of Medicine, University of Washington Medical Center, Seattle, WA) discusses the PREPIC2 study. The PREPIC2 results, publishe by The Hematologist